{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T07:37:25Z","timestamp":1782977845085,"version":"3.54.5"},"reference-count":35,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T00:00:00Z","timestamp":1726790400000},"content-version":"vor","delay-in-days":720,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Prevention of Alzheimer's Disease"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.14283\/jpad.2022.78","type":"journal-article","created":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T05:19:35Z","timestamp":1663305575000},"page":"708-714","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Age, Sex, Hypertension and HDL-C Alter Serum BACE1 Activity in Cognitively Normal Subjects: Implications for Alzheimer's Disease"],"prefix":"10.1016","volume":"9","author":[{"given":"C.","family":"Cervellati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Vergallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3579-7921","authenticated-orcid":false,"given":"Alessandro","family":"Trentini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Campo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Vieceli Dalla Sega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Rizzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Bonaccorsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Rosta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Renzini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Pacifico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Passaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Hampel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Zuliani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.14283\/jpad.2022.78_bib1","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/s41582-021-00520-w","article-title":"Developing the ATX(N) classification for use across the Alzheimer disease continuum","volume":"17","author":"Hampel","year":"2021","journal-title":"Nat Rev Neurol"},{"key":"10.14283\/jpad.2022.78_bib2","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jneumeth.2018.10.025","article-title":"Blood-based biomarkers for Alzheimer's disease-An update","volume":"319","author":"Zetterberg","year":"2019","journal-title":"J Neurosci Methods"},{"key":"10.14283\/jpad.2022.78_bib3","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimers Dement"},{"key":"10.14283\/jpad.2022.78_bib4","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s11357-019-00127-6","article-title":"Serum beta-secretase 1 (BACE1) activity as candidate biomarker for late-onset Alzheimer's disease","volume":"42","author":"Cervellati","year":"2020","journal-title":"Geroscience"},{"key":"10.14283\/jpad.2022.78_bib5","doi-asserted-by":"crossref","first-page":"14980","DOI":"10.1038\/s41598-020-72168-3","article-title":"Increased blood BACE1 activity as a potential common pathogenic factor of vascular dementia and late onset Alzheimer's disease","volume":"10","author":"Zuliani","year":"2020","journal-title":"Sci Rep"},{"key":"10.14283\/jpad.2022.78_bib6","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1111\/jnc.15513","article-title":"Serum beta-secretase 1 (BACE1) activity increases in patients with mild cognitive impairment","volume":"159","author":"Zuliani","year":"2021","journal-title":"J Neurochem"},{"key":"10.14283\/jpad.2022.78_bib7","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.biopsych.2017.02.007","article-title":"Increased Plasma Beta-Secretase 1 May Predict Conversion to Alzheimer's Disease Dementia in Individuals With Mild Cognitive Impairment","volume":"83","author":"Shen","year":"2018","journal-title":"Biol Psychiat"},{"issue":"1","key":"10.14283\/jpad.2022.78_bib8","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3233\/JAD-2010-1367","article-title":"BACE1 activity in cerebrospinal fluid and its relation to markers of AD pathology","volume":"20","author":"Mulder","year":"2010","journal-title":"J Alzheimers Dis"},{"key":"10.14283\/jpad.2022.78_bib9","doi-asserted-by":"crossref","first-page":"373","DOI":"10.3233\/JAD-2011-091153","article-title":"Increased CSF-BACE1 Activity Associated with Decreased Hippocampus Volume in Alzheimer's Disease","volume":"25","author":"Ewers","year":"2011","journal-title":"J Alzheimers Dis"},{"key":"10.14283\/jpad.2022.78_bib10","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1002\/jnr.23122","article-title":"Characterization of plasma \u03b2-secretase (BACE1) activity and soluble amyloid precursor proteins as potential biomarkers for Alzheimer's disease","volume":"90","author":"Wu","year":"2012","journal-title":"J Neurosci Res"},{"key":"10.14283\/jpad.2022.78_bib11","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1001\/archneur.59.9.1381","article-title":"\u03b2-Secretase Protein and Activity Are Increased in the Neocortex in Alzheimer Disease","volume":"59","author":"Fukumoto","year":"2002","journal-title":"Arch Neurol"},{"key":"10.14283\/jpad.2022.78_bib12","doi-asserted-by":"crossref","first-page":"3265","DOI":"10.1007\/s00018-008-8271-3","article-title":"Understanding BACE1: essential protease for amyloid-\u03b2 production in Alzheimer's disease","volume":"65","author":"Stockley","year":"2008","journal-title":"Cell Mol Life Sci"},{"key":"10.14283\/jpad.2022.78_bib13","article-title":"The \u03b2-Secretase BACE1 in Alzheimer's Disease","author":"Hampel","year":"2020","journal-title":"Biol Psychiat"},{"key":"10.14283\/jpad.2022.78_bib14","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1111\/j.1471-4159.2009.06181.x","article-title":"The amyloid hypothesis for Alzheimer's disease: a critical reappraisal","volume":"110","author":"Hardy","year":"2009","journal-title":"J Neurochem"},{"key":"10.14283\/jpad.2022.78_bib15","doi-asserted-by":"crossref","first-page":"5481","DOI":"10.1038\/s41380-021-01249-0","article-title":"The Amyloid-\u03b2 Pathway in Alzheimer's Disease","volume":"26","author":"Hampel","year":"2021","journal-title":"Mol Psychiatr"},{"key":"10.14283\/jpad.2022.78_bib16","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/j.jalz.2019.07.001","article-title":"Brain A\u03b2 load association and sexual dimorphism of plasma BACE1 concentrations in cognitively normal individuals at risk for AD","volume":"15","author":"Vergallo","year":"2019","journal-title":"Alzheimers Dement"},{"key":"10.14283\/jpad.2022.78_bib17","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s13195-017-0283-5","article-title":"On the path to 2025: understanding the Alzheimer's disease continuum","volume":"9","author":"Aisen","year":"2017","journal-title":"Alzheimers Res Ther"},{"key":"10.14283\/jpad.2022.78_bib18","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1001\/archneur.65.8.1102","article-title":"Elevated cerebrospinal fluid BACE1 activity in incipient Alzheimer disease","volume":"65","author":"Zetterberg","year":"2008","journal-title":"Arch Neurol"},{"key":"10.14283\/jpad.2022.78_bib19","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/alz.12228","article-title":"Plasma \u03b2-secretase1 concentrations correlate with basal forebrain atrophy and neurodegeneration in cognitively healthy individuals at risk for AD","volume":"17","author":"Vergallo","year":"2021","journal-title":"Alzheimers Dement"},{"key":"10.14283\/jpad.2022.78_bib20","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/j.jalz.2019.07.001","article-title":"Brain A\u03b2 load association and sexual dimorphism of plasma BACE1 concentrations in cognitively normal individuals at risk for AD","volume":"15","author":"Vergallo","year":"2019","journal-title":"Alzheimers Dement"},{"key":"10.14283\/jpad.2022.78_bib21","doi-asserted-by":"crossref","first-page":"P356","DOI":"10.1093\/geronb\/56.6.P356","article-title":"The Effects of Age, Education, and Gender on the Mattis Dementia Rating Scale Performance of Elderly Chinese and American Individuals","volume":"56","author":"Chan","year":"2001","journal-title":"J Gerontol B Psychol Sci Soc Sci"},{"key":"10.14283\/jpad.2022.78_bib22","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jsbmb.2016.03.012","article-title":"Age, APOE and sex: Triad of risk of Alzheimer's disease","volume":"160","author":"Riedel","year":"2016","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.14283\/jpad.2022.78_bib23","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1001\/jama.2017.11217","article-title":"Menopausal Hormone Therapy and Long-term All-Cause and Cause-Specific Mortality: The Women's Health Initiative Randomized Trials","volume":"318","author":"Manson","year":"2017","journal-title":"JAMA"},{"key":"10.14283\/jpad.2022.78_bib24","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/s41582-018-0032-9","article-title":"Sex differences in Alzheimer disease \u2014 the gateway to precision medicine","volume":"14","author":"Ferretti","year":"2018","journal-title":"Nat Rev Neurol"},{"key":"10.14283\/jpad.2022.78_bib25","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1093\/brain\/awn034","article-title":"Increased CSF-BACE 1 activity is associated with ApoE-\u03b54 genotype in subjects with mild cognitive impairment and Alzheimer's disease","volume":"131","author":"Ewers","year":"2008","journal-title":"Brain"},{"key":"10.14283\/jpad.2022.78_bib26","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.neuroscience.2018.01.005","article-title":"Profiles of \u03b2-Amyloid Peptides and Key Secretases in Brain Autopsy Samples Differ with Sex and APOE \u03b54 Status: Impact for Risk and Progression of Alzheimer Disease","volume":"373","author":"Nyarko","year":"2018","journal-title":"Neuroscience"},{"key":"10.14283\/jpad.2022.78_bib27","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1756-6606-3-34","article-title":"Sex- and brain region-specific acceleration of \u03b2-amyloidogenesis following behavioral stress in a mouse model of Alzheimer's disease","volume":"3","author":"Devi","year":"2010","journal-title":"Mol Brain"},{"key":"10.14283\/jpad.2022.78_bib28","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1136\/bmj.308.6944.1604","article-title":"Cardiovascular disease and distribution of cognitive function in elderly people: the Rotterdam Study","volume":"308","author":"Breteler","year":"1994","journal-title":"BMJ"},{"key":"10.14283\/jpad.2022.78_bib29","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1161\/01.STR.0000014421.15948.67","article-title":"Alzheimer Disease as a Vascular Disorder","volume":"33","author":"de la Torre","year":"2002","journal-title":"Stroke"},{"key":"10.14283\/jpad.2022.78_bib30","first-page":"2617970","article-title":"Alzheimer's Disease and Cardiovascular Disease: A Particular Association","author":"Tini","year":"2020","journal-title":"Cardiol Res Pract"},{"key":"10.14283\/jpad.2022.78_bib31","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.neuropharm.2017.12.030","article-title":"The pathology and pathophysiology of vascular dementia","volume":"134","author":"Kalaria","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.14283\/jpad.2022.78_bib32","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1006\/nbdi.2002.0515","article-title":"Oxidative stress increases expression and activity of BACE in NT2 neurons","volume":"10","author":"Tamagno","year":"2002","journal-title":"Neurobiol Dis"},{"key":"10.14283\/jpad.2022.78_bib33","doi-asserted-by":"crossref","first-page":"101662","DOI":"10.1016\/j.pneurobio.2019.101662","article-title":"Time for the systems-level integration of aging: Resilience enhancing strategies to prevent Alzheimer's disease","volume":"181","author":"Hampel","year":"2019","journal-title":"Prog Neurobiol"},{"issue":"2","key":"10.14283\/jpad.2022.78_bib34","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1212\/WNL.0000000000006745","article-title":"Translating the biology of aging into novel therapeutics for Alzheimer disease","volume":"92","author":"Hara","year":"2019","journal-title":"Neurology"},{"key":"10.14283\/jpad.2022.78_bib35","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s13195-020-00686-3","article-title":"\u03b2-Secretase1 biological markers for Alzheimer's disease: state-of-art of validation and qualification","volume":"12","author":"Hampel","year":"2020","journal-title":"Alzheimers Res Ther"}],"container-title":["The Journal of Prevention of Alzheimer's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580724002802?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580724002802?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T00:41:55Z","timestamp":1736469715000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2274580724002802"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S2274580724002802"],"URL":"https:\/\/doi.org\/10.14283\/jpad.2022.78","relation":{},"ISSN":["2274-5807"],"issn-type":[{"value":"2274-5807","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Age, Sex, Hypertension and HDL-C Alter Serum BACE1 Activity in Cognitively Normal Subjects: Implications for Alzheimer's Disease","name":"articletitle","label":"Article Title"},{"value":"The Journal of Prevention of Alzheimer's Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.14283\/jpad.2022.78","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2022 THE AUTHORS. Published by Elsevier Masson SAS on behalf of SERDI Publisher. Published by Elsevier Masson SAS","name":"copyright","label":"Copyright"}]}}